Remote Ischemic Preconditioning (RIPC) versus sham-control for prevention of anastomotic leakage after resection for Esophageal cancer: a prospective, randomized controlled, triple-blind, clinical phase III monocenter trial
Phase 3
- Conditions
- C15.9K91.83Oesophagus, unspecified
- Registration Number
- DRKS00018934
- Lead Sponsor
- Medizinische Fakultät Mannheim
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Persons meeting the following criteria may be included in the study:
• Planned elective esophagus resection for esophageal cancer
• Signed informed consent
• Age =18 years
Exclusion Criteria
Persons meeting any of the following criteria cannot be included in the study:
• Patients not able to give informed consent
• Patients presenting with the following contraindications to the study intervention (RIPC): arterial occlusive disease (AOD), infections or wounds on the upper extremity, poorly controlled diabetes mellitus, or deep vein thrombosis of the upper extremity
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method